Clinical Scorecard: Influence of Immunity to Non-Dengue Flaviviruses on the Specificity of Dengue Virus IgG ELISA in Cambodia
At a Glance
Category
Detail
Condition
Dengue virus infection and serological cross-reactivity with other flaviviruses
Key Mechanisms
Cross-reactive antibodies from immunity to non-dengue flaviviruses (Zika, Japanese encephalitis, West Nile) reduce specificity of dengue IgG ELISA assays
Target Population
Children aged 2–9 years in dengue-endemic Cambodia
Care Setting
Public health surveillance and clinical settings assessing dengue immunity and vaccine eligibility
Key Highlights
PanBio indirect dengue virus IgG ELISA showed lower specificity (58%) in Cambodian children compared to prior reports (93%–100%)
46% of false-positive dengue IgG ELISA results had neutralizing antibodies against other flaviviruses, including 14% against West Nile virus
Adjusting the IgG ELISA cut point improved test accuracy in this population with flavivirus co-circulation
Guideline-Based Recommendations
Diagnosis
Use plaque reduction neutralization tests (PRNT) as gold standard for confirming dengue immunity when possible
Be cautious interpreting dengue IgG ELISA results in areas with co-circulating flaviviruses due to cross-reactivity
Management
Consider flavivirus co-circulation and vaccination history when assessing dengue seroprevalence and vaccine eligibility
Adjust ELISA cut points to improve specificity in populations with known flavivirus exposure
Monitoring & Follow-up
Monitor for emerging flaviviruses such as West Nile virus in Cambodia and similar endemic regions
False-positive dengue IgG ELISA results may lead to inappropriate vaccine administration, especially in dengue-naive individuals
Cross-reactive immunity may complicate surveillance and risk stratification for dengue vaccination
Patient & Prescribing Data
Children aged 2–9 years in dengue-endemic Cambodia with potential exposure to multiple flaviviruses
Accurate serological testing is critical to determine dengue vaccine eligibility; false positives due to flavivirus cross-reactivity may increase risk of severe dengue if vaccinated inappropriately
Clinical Best Practices
Use highly specific confirmatory tests like PRNT to validate dengue IgG ELISA results in flavivirus-endemic areas
Incorporate knowledge of local flavivirus epidemiology and vaccination programs when interpreting serological data
Adjust ELISA assay cut points based on local validation studies to improve diagnostic accuracy
Remain vigilant for emerging flaviviruses such as West Nile virus that may affect serological testing and public health responses
by Camila D Odio, Christina Yek, Chloe M Hasund, Somnang Man, Piseth Ly, Sreynik Nhek, Sophana Chea, Chanthap Lon, Charlie Voirin, Rekol Huy, Rithea Leang, Chea Huch, Elaine W Lamirande, Stephen S Whitehead, Fabiano Oliveira, Jessica E Manning, Leah C Katzelnick
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
